APEPTICO

APEPTICO is a privately-owned biotechnology company based in Austria, developing peptide-based products targeting chronic and life-threatening diseases. Peptide molecules correspond to the proven pharmacodynamic active structures and domains of known proteins and biopharmaceuticals. By focusing on synthetic protein structures, APEPTICO avoids the general risks associated with gene and cell technologies. APEPTICO leverages its technical platforms PEPBASE(TM) and PEPSCREEN(TM) to significantly reduce costs and shorten time-to-market.